歐洲電生理學市場：分析與預測（2024-2034）

預計歐洲電生理學市場規模將從 2024 年的 24.9 億美元成長到 2034 年的 76.4 億美元，2024-2034 年預測期間的複合年成長率為 11.85%。

心血管疾病（尤其是心律不整）盛行率的上升，以及 3D心臟定位、心導管電氣燒灼術平台和先進診斷系統等新技術的快速發展，正在推動歐洲電生理設備市場的發展。人口老化導致心臟病的風險更高，對微創手術的需求也日益成長。由於導管消融手術風險低、恢復快，因此更受青睞。公眾對心臟健康的認知不斷提高、歐洲醫療保健系統的不斷改善以及公共和商業實體的重點投資都是推動市場快速擴張的因素之一。

市場介紹

心律不整（尤其是心房顫動）的盛行率不斷上升，以及對微創心血管手術的需求不斷成長，推動著歐洲電生理 (EP) 產業的發展。隨著歐洲人口老化導致心律不整盛行率增加，早期診斷和有效治療在臨床和經濟上變得越來越重要。 3D心臟定位系統、射頻導管、冷凍消融導管和人工智慧導航平台等先進技術正在徹底改變電生理學家識別、定位和治療心臟異常電活動的方式。

歐洲醫療保健系統，尤其是西方和北歐地區，正在投資結合影像處理、映射和機器人導管控制的數位技術以及最先進的 EP 實驗室和混合手術室。優惠的報銷條件鼓勵醫院改善基礎設施並增加服務項目，尤其是心房顫動消融治療。同時，對穿戴式心臟監測和門診手術的需求正在改變病患照護模式。

但仍存在困難。儘管如此，設備成本上升、合格電生理學家短缺以及歐盟各國醫療報銷差異阻礙了廣泛採用。由於遵守歐盟醫療設備法規，製造商面臨額外的複雜性。然而，由於強勁的臨床需求和技術創新步伐，歐洲 EP 產業已準備好實現持續成長。

歐洲電生理學市場的趨勢、促進因素與挑戰

趨勢

• 採用高解析度3D和超高密度心臟定位系統
• 整合人工智慧和機器學習，實現心律不整基材物的自動識別
• 遠端和機器人導管導航平台的成長
• EP 成像複合物的出現（MRI/CT 和映射的疊加）
• 擴展穿戴式和植入式監測設備，用於連續心律監測

驅動程式

• 歐洲老化社會中心心房顫動和其他心律不整的盛行率不斷上升
• 強而有力的臨床證據支持微創心導管電氣燒灼術手術
• 西歐各地針對高級 EP 干預措施的報銷支持
• 透過設備製造商、醫院和研究機構之間的合作促進技術創新
• 病人和醫生對更安全、更有效的心律不整治療的需求日益增加

任務

• 最先進的 EP 實驗室和設備的資本和維護成本高昂
• 歐盟成員國報銷框架分散，醫院預算波動
• 需要專門培訓，缺乏經驗豐富的電生理學家
• 新的環保技術監管複雜且核准流程漫長
• 傳統醫院 IT 系統與新 EP 平台之間的資料整合和互通性障礙

成長/行銷策略：夥伴關係、聯盟和業務擴展佔 2022 年 1 月至 2024 年 12 月歐洲電生理學市場關鍵發展的最大數量。

競爭策略：歐洲電生理學市場有大量現有參與者及其產品和服務組合。本研究分析和描述的歐洲電生理學市場的主要企業包括提供電生理學產品和服務的現有公司。

主要市場參與企業及競爭格局

所介紹的公司是根據從頂尖專家收集的意見以及對公司覆蓋範圍、產品系列和市場滲透率的分析而選出的。

本報告研究了歐洲電生理學市場，提供了市場概況以及各國趨勢和參與市場的公司概況。

目錄

執行摘要

第1章市場：產業展望

• 產業展望
  • 供應鏈概覽
  • 贖回方案
  • 價值鏈分析
• 趨勢：現況與未來影響評估
  • 先進 3D 地圖系統和即時成像技術的採用率不斷提高
  • 人工智慧在預測模型和個人化醫療的新興應用
• 專利分析
  • 專利申請趨勢（按國家和年份）
• 法律規範
  • 歐洲聯盟
  • 英國
  • 法國
  • 德國
  • 義大利
  • 西班牙
• 市場動態概覽
  • 市場促進因素
  • 市場限制
  • 市場機會

第2章 電生理學市場（按地區分類），百萬美元，2022-2034 年

• 區域摘要
• 歐洲
  • 區域概況
  • 市場成長動力
  • 成長抑制因素
  • 法國
  • 義大利
  • 德國
  • 英國
  • 西班牙
  • 其他

第3章 市場競爭基準化分析與公司概況

• 電生理學市場：競爭格局
  • 企業策略 2019 年 1 月 - 2024 年 12 月
  • 策略性舉措（按會計年度），2019 年 1 月至 2024 年 12 月
  • 夥伴關係、聯盟和業務擴展
  • 新服務
  • 監管部門核准
  • 資金籌措活動
  • 合併與收購
  • 2015 年至 2023 年的關鍵發展與里程碑
• 公司簡介
  • Koninklijke Philips NV
  • Siemens Healthineers AG
  • Volta Medical
  • CathVision ApS
  • Biotronik

第4章調查方法

Introduction to Europe Electrophysiology Market

The Europe electrophysiology market is projected to reach $7.64 billion by 2034 from $2.49 billion in 2024, growing at a CAGR of 11.85% during the forecast period 2024-2034. The rising prevalence of cardiovascular disorders, particularly arrhythmias, and the quick development of new technologies such as 3D cardiac mapping, catheter ablation platforms, and sophisticated diagnostic systems are driving the market for electrophysiology devices in Europe. The need for minimally invasive procedures is increasing due to an ageing population at higher risk of heart diseases; catheter-based ablations are preferred because of their lowered procedural risks and quicker recovery. Increased public awareness of heart health, ongoing improvements to the European healthcare system, and focused investments from public and commercial entities are all contributing to the market's rapid expansion.

Market Introduction

The growing incidence of arrhythmias, especially atrial fibrillation, and the growing need for minimally invasive cardiac procedures are driving the electrophysiology (EP) industry in Europe. Due to the increased prevalence of heart rhythm abnormalities brought on by Europe's ageing population, early diagnosis and efficient treatment are becoming more and more important from a clinical and financial standpoint. The way electrophysiologists identify, locate, and treat aberrant electrical activity in the heart is being revolutionised by advanced technology like 3D cardiac mapping systems, radiofrequency and cryoablation catheters, and AI-enabled navigation platforms.

Digital technologies that combine imaging, mapping, and robotic catheter control, as well as contemporary EP labs and hybrid operating suites, are being invested in by European healthcare systems, particularly those in the Western and Nordic areas. Favourable reimbursement conditions are pushing hospitals to improve infrastructure and increase service offerings, especially for atrial fibrillation ablation. In the meantime, patient care paradigms are changing due to the desire for wearable cardiac monitoring and outpatient operations.

But there are still difficulties. Adoption is nevertheless hampered by high equipment prices, a shortage of qualified electrophysiologists, and disparities in reimbursement between EU nations. Manufacturers are further complicated by regulatory compliance under the EU Medical Device Regulation. Nonetheless, Europe's EP industry is well-positioned for sustained growth due to robust clinical need and innovation pace.

Market Segmentation:

Segmentation 1: by Region

• Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest-of-Europe

Europe Electrophysiology Market Trends, Drivers and Challenges

Trends

• Adoption of high-resolution 3D and ultra-high-density cardiac mapping systems
• Integration of AI and machine learning for automated arrhythmia substrate identification
• Growth of remote and robotic catheter navigation platforms
• Emergence of combined EP-imaging suites (MRI/CT overlay with mapping)
• Expansion of wearable and implantable monitoring devices for continuous rhythm surveillance

Drivers

• Increasing prevalence of atrial fibrillation and other arrhythmias in Europe's aging population
• Strong clinical evidence favoring minimally invasive catheter-ablation procedures
• Reimbursement support across Western Europe for advanced EP interventions
• Collaboration between device makers, hospitals and research institutes accelerating innovation
• Heightened patient and physician demand for safer, more effective heart-rhythm therapies

Challenges

• High capital and maintenance costs for state-of-the-art EP labs and equipment
• Fragmented reimbursement frameworks and variable hospital budgets across EU member states
• Need for specialized training and scarcity of experienced electrophysiologists
• Regulatory complexity and lengthy approval pathways for novel EP technologies
• Data-integration and interoperability hurdles between legacy hospital IT systems and new EP platforms

How can this report add value to an organization?

Growth/Marketing Strategy: The partnership, alliance, and business expansion accounted for the maximum number of key developments in the Europe electrophysiology market between January 2022 and December 2024.

Competitive Strategy: The Europe electrophysiology market has numerous established players with product and service portfolios. Key players in the Europe electrophysiology market analyzed and profiled in the study involve established players offering electrophysiology products and services.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, type portfolio, and market penetration.

Some prominent names in the Europe electrophysiology market include:

• Siemens Healthineers AG
• Biotronik
• Koninklijke Philips N.V.

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

• 1.1 Industry Outlook
  • 1.1.1 Supply Chain Overview
    • 1.1.1.1 Risks within the Supply Chain
  • 1.1.2 Reimbursement Scenario
    • 1.1.2.1 Overview
    • 1.1.2.2 Europe
  • 1.1.3 Value Chain Analysis
    • 1.1.3.1 Overview
    • 1.1.3.2 Stakeholders at Each Stage of the Value Chain
    • 1.1.3.3 Strategic Partnerships, Mergers, and Acquisitions in the Value Chain
• 1.2 Trends: Current and Future Impact Assessment
  • 1.2.1 Increasing Adoption of Advanced 3D Mapping Systems and Real-Time Imaging
  • 1.2.2 Emerging Use of Artificial Intelligence in Predictive Modelling and Personalized Treatment
• 1.3 Patent Analysis
  • 1.3.1 Patent Filing Trend (by Country, Year)
• 1.4 Regulatory Framework
  • 1.4.1 European Union (EU)
  • 1.4.2 U.K.
  • 1.4.3 France
  • 1.4.4 Germany
  • 1.4.5 Italy
  • 1.4.6 Spain
• 1.5 Market Dynamics Overview
  • 1.5.1 Market Drivers
    • 1.5.1.1 Innovative Technological Developments
    • 1.5.1.2 Proliferation of New Entrants and Its Market Implications
    • 1.5.1.3 Expanding Investments, Funding, and Grant Support for Cardiac Surgery and Electrophysiology
    • 1.5.1.4 Increasing Disease Incidence and Procedural Volume
  • 1.5.2 Market Restraints
    • 1.5.2.1 High Product Costs and Inadequate Reimbursement Policies
    • 1.5.2.2 Increasing Device Reuse and Reprocessing Trends
  • 1.5.3 Market Opportunities
    • 1.5.3.1 Expansion of Emerging Markets
    • 1.5.3.2 Next-Generation Ablation Technologies

2 Electrophysiology Market (by Region), $Million, 2022-2034

• 2.1 Regional Summary
• 2.2 Europe
  • 2.2.1 Regional Overview
  • 2.2.2 Driving Factors for Market Growth
  • 2.2.3 Factors Challenging the Market
  • 2.2.4 France
  • 2.2.5 Italy
  • 2.2.6 Germany
  • 2.2.7 U.K.
  • 2.2.8 Spain
  • 2.2.9 Rest-of-Europe

3 Markets - Competitive Benchmarking & Company Profiles

• 3.1 Electrophysiology Market: Competitive Landscape
  • 3.1.1 Corporate Strategies, January 2019-December 2024
  • 3.1.2 Strategic Initiatives (by Year), January 2019-December 2024
  • 3.1.3 Partnerships, Alliances, and Business Expansions
  • 3.1.4 New Offerings
  • 3.1.5 Regulatory Approval
  • 3.1.6 Funding Activities
  • 3.1.7 Merger and Acquisition
  • 3.1.8 Key Developments and Milestones, 2015-2023
• 3.2 Company Profiles
  • 3.2.1 Koninklijke Philips N.V.
    • 3.2.1.1 Overview
    • 3.2.1.2 Top Products
    • 3.2.1.3 Top Competitors
    • 3.2.1.4 Target Customers
    • 3.2.1.5 Analyst View
  • 3.2.2 Siemens Healthineers AG
    • 3.2.2.1 Overview
    • 3.2.2.2 Top Products
    • 3.2.2.3 Top Competitors
    • 3.2.2.4 Target Customers
    • 3.2.2.5 Analyst View
  • 3.2.3 Volta Medical
    • 3.2.3.1 Overview
    • 3.2.3.2 Top Products
    • 3.2.3.3 Top Competitors
    • 3.2.3.4 Target Customers
    • 3.2.3.5 Analyst View
  • 3.2.4 CathVision ApS
    • 3.2.4.1 Overview
    • 3.2.4.2 Top Products
    • 3.2.4.3 Top Competitors
    • 3.2.4.4 Target Customers
    • 3.2.4.5 Analyst View
  • 3.2.5 Biotronik
    • 3.2.5.1 Overview
    • 3.2.5.2 Top Products
    • 3.2.5.3 Top Competitors
    • 3.2.5.4 Target Customers
    • 3.2.5.5 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast

List of Figures

• Figure 1: Key Events to Keep Track of within the Electrophysiology Market
• Figure 2: Supply Chain and Risks within the Supply Chain
• Figure 3: Electrophysiology Market, Patent Analysis (by Country), January 2021-December 2024
• Figure 4: Electrophysiology Market, Patent Analysis (by Year), January 2021-December 2024
• Figure 5: Europe Electrophysiology Market, $Billion, 2022-2034
• Figure 6: France Electrophysiology Market, $Billion, 2022-2034
• Figure 7: Italy Electrophysiology Market, $Billion, 2022-2034
• Figure 8: Germany Electrophysiology Market, $Billion, 2022-2034
• Figure 9: U.K. Electrophysiology Market, $Billion, 2022-2034
• Figure 10: Spain Electrophysiology Market, $Billion, 2022-2034
• Figure 11: Rest-of-Europe Electrophysiology Market, $Billion, 2022-2034
• Figure 12: Corporate Strategies, January 2019-December 2024
• Figure 13: Share of Strategic Initiatives, January 2019-December 2024
• Figure 14: Strategic Initiatives (by Year), January 2019-December 2024
• Figure 15: Partnerships, Alliances, and Business Expansions, January 2019-December 2024
• Figure 16: New Offerings, January 2019-December 2024
• Figure 17: Regulatory Approval, January 2019-December 2024
• Figure 18: Funding Activities, January 2019-December 2024
• Figure 19: Merger And Acquisition, January 2019-December 2024
• Figure 20: Data Triangulation
• Figure 21: Top-Down and Bottom-Up Approach
• Figure 22: Assumptions and Limitations

List of Tables

• Table 1: Market Snapshot
• Table 2: Electrophysiology Market Trend Analysis
• Table 3: Impact Analysis of Market Navigating Factors, 2024-2034
• Table 4: Electrophysiology Market (by Region), $Billion, 2022-2034